Literature DB >> 4062450

Tubulointerstitial renal disease in systemic lupus erythematosus.

J R O'Dell, R C Hays, S J Guggenheim, J C Steigerwald.   

Abstract

Tubulointerstitial renal disease is found frequently in patients with systemic lupus erythematosus. Despite the frequency of this entity, little is known about the prognostic significance of this biopsy finding. We reviewed 46 consecutive renal biopsy specimens from patients with systemic lupus erythematosus who were followed up for a mean of 5.4 years. Tubulointerstitial abnormalities were present in 39% of the entire group of patients and in 51% of the patients who had clinical evidence of renal abnormalities. Tubulointerstitial inflammation was closely associated with diffuse proliferative glomerulonephritis, with elevation of serum creatinine (SCr) concentration at biopsy, and with increased frequency of proteinuria both at biopsy and at follow-up. Additionally, active interstitial inflammation was associated with an increased risk of doubling the entry SCr concentration. The presence or absence of tubulointerstitial disease, however, did not add additional prognostic information to the predictive power of the entry SCr concentration or the glomerular histologic features.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4062450

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

Authors:  Anna Broder; Wenzhu B Mowrey; Hina N Khan; Bojana Jovanovic; Alejandra Londono-Jimenez; Peter Izmirly; Chaim Putterman
Journal:  Semin Arthritis Rheum       Date:  2017-07-14       Impact factor: 5.532

2.  Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival.

Authors:  Chao-Yi Wu; Huang-Yu Yang; Hui-Ping Chien; Min-Hua Tseng; Jing-Long Huang
Journal:  Pediatr Nephrol       Date:  2018-03-06       Impact factor: 3.714

3.  Time course and localization of endothelin-1 gene expression in a model of renal disease progression.

Authors:  I Bruzzi; D Corna; C Zoja; S Orisio; E L Schiffrin; D Cavallotti; G Remuzzi; A Benigni
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

4.  Interstitial nephritis induced by protein-overload proteinuria.

Authors:  A A Eddy
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

5.  A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome.

Authors:  A A Eddy; L McCulloch; E Liu; J Adams
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

6.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring.

Authors:  Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O Utset; Marcus R Clark
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-06       Impact factor: 4.794

7.  Renal tubular dysfunction in children with systemic lupus erythematosus.

Authors:  Stephen D Marks; Vanita Shah; Clarissa Pilkington; Patricia Woo; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2004-12-28       Impact factor: 3.714

8.  A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus.

Authors:  O T Chan; L G Hannum; A M Haberman; M P Madaio; M J Shlomchik
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

9.  Hypokalemic Paralysis: A Hidden Card of Several Autoimmune Diseases.

Authors:  Yelitza Velarde-Mejía; Rocío Gamboa-Cárdenas; Manuel Ugarte-Gil; César Pastor Asurza
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2017-08-03

10.  Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.

Authors:  George K Bertsias; Maria Tektonidou; Zahir Amoura; Martin Aringer; Ingeborg Bajema; Jo H M Berden; John Boletis; Ricard Cervera; Thomas Dörner; Andrea Doria; Franco Ferrario; Jürgen Floege; Frederic A Houssiau; John P A Ioannidis; David A Isenberg; Cees G M Kallenberg; Liz Lightstone; Stephen D Marks; Alberto Martini; Gabriela Moroni; Irmgard Neumann; Manuel Praga; Matthias Schneider; Argyre Starra; Vladimir Tesar; Carlos Vasconcelos; Ronald F van Vollenhoven; Helena Zakharova; Marion Haubitz; Caroline Gordon; David Jayne; Dimitrios T Boumpas
Journal:  Ann Rheum Dis       Date:  2012-07-31       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.